Major Achievements

(Publications)

Ayoub Moubareck C, Mouftah S., Pál T., Ghazawi A., Halat D., Nabi A., AlSharhan M., AlDeesi Z., Peters C., Celiloglu H., Sannegowda M., Sarkis D., Sonnevend A. Clonal emergence of Klebsiella pneumoniae ST14 co-producing OXA-48-type and NDM carbapenemases with high rate of colistin resistance in Dubai, United Arab Emirates. International Journal of Antimicrobial Agents (Q1). 2018, Jul; 52(1):90-95.

Itani T, Ayoub Moubareck C, Melki I, Rousseau C, Mangin I, Butel MJ, Karam Sarkis D. Preterm infants with necrotising enterocolitis demonstrate an unbalanced gut microbiota. Acta Paediatrica (Q2). 2018, Jan 107 (1) :40-47.

Hammoudi Halat, D., Ayoub Moubareck, C., Karam Sarkis, D. Heterogeneity of carbapenem resistance mechanisms among Gram-negative pathogens in Lebanon: results of the first cross-sectional countrywide study. Microbial Drug Resistance (Q2). 2017, Sep; 23(6):733-743.

Itani T, Ayoub Moubareck C, Melki I, Rousseau C, Mangin I, Butel MJ, Karam Sarkis D. Establishment and development of the intestinal microbiota of preterm infants in a Lebanese tertiary hospital. Anaerobe (Q2). 2017 Feb: 43:4-14.

Hammoudi D, Ayoub Moubareck C, Hakime N, Houmani M, Barakat A, Najjar Z, Suleiman M, Fayad N, Sarraf R, Sarkis DK. Spread of imipenem-resistant Acinetobacter baumannii co-expressing OXA-23 and GES-11 carbapenemases in Lebanon. International Journal of Infectious Diseases (Q2). 2015 Jul; 36:56-61.

Hammoudi D, Ayoub Moubareck C, Kanso A, Nordmann P, Karam Sarkis D. 2014. Surveillance of carbapenem non-susceptible gram negative strains and characterization of carbapenemases of classes A, B, and D in a Lebanese hospital. Lebanese Medical Journal. 2015 Apr-Jun; 63(2):66-73.

Hammoudi D, Ayoub Moubareck C, Aires J, Adaime A, Barakat A, Fayad N, Hakime N, Houmani M, Itani T, Najjar Z, Suleiman M, Sarraf R, Karam Sarkis D. 2014. Countrywide spread of OXA-48 carbapenemase in Lebanon : surveillance and genetic characterization of carbapenem-nonsusceptible Enterobacteriaceae in 10 hospitals over a one-year period. International Journal of Infectious Diseases (Q2). 29 (2014) 139-144.

Hammoudi D, Ayoub Moubareck C, Karam Sarkis D. 2014. How to detect carbapenemase producers? A literature review of phenotypic and molecular methods. Journal Microbiological Methods (Q2). (107):106-18.

Granier SA, Moubareck C, Colaneri C, Lemire A, Roussel S, Dao TT, Courvalin P, Brisabois A. 2011. Antimicrobial resistance of Listeria monocytogenes isolated from food and environment in France over a 10 year period. Applied and Environmental Microbiology (Q1). 77(8):2788-790.

Lascols C, Legrand P, Mérens A, Leclercq R, Muller-Serieys C, Drugeon HB, Kitzis MD, Reverdy ME, Roussel-Delvallez M, Moubareck C, Brémont S, Miara A, Gjoklaj M, Soussy CJ. 2011. In vitro antibacterial activity of ceftobiprole against clinical isolates from French teaching hospitals: proposition of zone diameter breakpoints. International Journal of Antimicrobial Agents (Q1). 37(3):235-9.

Lascols C., Legrand P., Mérens A., Leclercq R., Armand-Lefevre L., Drugeon H.B., Kitzis M.D., Muller-Serieys C., Reverdy M.E., Roussel-Delvallez M., Moubareck C., Lemire A., Miara A., Gjoklaj M., Soussy C.J. 2011. In vitro antibacterial activity of doripenem against clinical isolates from French teaching hospitals. Proposition of zone diameters breakpoints. European Journal of Clinical Microbiology & Infectious Diseases (Q1). 30(4):475-82.

Meziane-Cherif D., Saul F.A., Moubareck C., Weber P., Haouz A., Courvalin P., Périchon B. 2010. Molecular basis of vancomycin-dependence in VanA-type Staphylococcus aureus VRSA-9. Journal of Bacteriology (Q1). 192(20):5465-71.

Morvan A., Moubareck C., Leclercq A., Hervé-Bazin M., Bremont S., Lecuit M., Courvalin P., and Le Monnier A. 2010. Antimicrobial resistance of Listeria monocytogenes human strains isolated in France. Antimicrobial Agents and Chemotherapy (Q1). 54(6):2728-31.

Moubareck C., Meziane-Cherif D., Courvalin P., Périchon B. 2009. VanA type Staphylococcus aureus VRSA-7 is dependent on vancomycin for growth. Antimicrobial Agents and Chemotherapy (Q1). 53(9):3657-63.

Moubareck C., Brémont S., Conroy M.C., Courvalin P., Lambert T. 2009. GES-11, a novel integron-associated GES variant, in Acinetobacter baumannii. Antimicrobial Agents and Chemotherapy (Q1). 53(8):3579-81.

Moubareck C., Lecso M., Pinloche E., Butel M.J., Doucet-Populaire F. 2007. Inhibitory impact of Bifidobacteria on the transfer of -lactam resistance among Enterobacteriaceae in the digestive tract of gnotobiotic mice. Applied and Environmental Microbiology (Q1). 73(3):855-60.

Daoud Z., Moubareck C., Hakimé N., Doucet-Populaire F. 2006. Extended spectrum -lactamase producing Enterobacteriaceae in Lebanese ICU patients: epidemiology and patterns of resistance. Journal of General and Applied Microbiology. 52 (3):169-78.

Bourgeois-Nicolaos N., Moubareck C., Nicole N., Butel M.J., Doucet-Populaire F. 2006. Comparative study of vanA gene transfer from Enterococcus faecium to Enterococcus faecalis and to E. faecium in the intestine of mice. FEMS Microbiology Letters. 254 (1):27-33.

Moubareck C., Daoud Z., Hakimé N., Hamzé M., Mangeney N., Matta H., Mokhbat J., Rohban R., Karam Sarkis D., Doucet-Populaire F. 2005. Countrywide spread of extended spectrum -lactamase (CTX-M-15)-producing Enterobacteriacae in Lebanon. Journal of Clinical Microbiology. 43 (7):3309-13.

Moubareck C., Hamze M., Daoud Z., Weill F.-X., Doucet-Populaire F. 2005. First Extended-Spectrum Beta-Lactamase (CTX-M-15)-producing strain of Salmonella enterica serotype Typhimurium identified in Lebanon. Antimicrobial Agents and Chemotherapy. 49 (2):864-865.

Moubareck C., Gavini F., Vaugien L., Butel M.J., Doucet-Populaire F. 2005. Antimicrobial susceptibility of Bifidobacteria. Journal of Antimicrobial Chemotherapy. 55:38-44

Moubareck C., Bourgeois N., Courvalin P., Doucet-Populaire F. 2003. Multiple antibiotic resistance gene transfer from animal to human enterococci in the digestive tract of gnotobiotic mice. Antimicrobial Agents and Chemotherapy. 47 (9):2993-2996.